Cargando…

Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2

BACKGROUND: Dengue virus (DENV) is a significant public health threat in tropical and subtropical regions of the world. A therapeutic antibody against the viral envelope (E) protein represents a promising immunotherapy for disease control. METHODOLOGY/PRINCIPAL FINDINGS: We generated seventeen novel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Pi-Chun, Liao, Mei-Ying, Cheng, Ping-Chang, Liang, Jian-Jong, Liu, I-Ju, Chiu, Chien-Yu, Lin, Yi-Ling, Chang, Gwong-Jen J., Wu, Han-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341331/ https://www.ncbi.nlm.nih.gov/pubmed/22563515 http://dx.doi.org/10.1371/journal.pntd.0001636

Ejemplares similares

Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein
por: Tang, Chung-Tao, et al.
Publicado: (2015)

Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement
por: Hughes, Holly R, et al.
Publicado: (2012)

Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody
por: Shen, Wen-Fan, et al.
Publicado: (2018)

Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay
por: Lin, Hong-En, et al.
Publicado: (2012)

Production and Purification of Dengue Virus-like Particles from COS-1 Cells
por: Galula, Jedhan Ucat, et al.
Publicado: (2019)

An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2
por: Tang, Chung-Tao, et al.
Publicado: (2015)

Comparative analysis of full genomic sequences among different genotypes of dengue virus type 3
por: King, Chwan-Chuen, et al.
Publicado: (2008)

Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens
por: Crill, Wayne D., et al.
Publicado: (2009)

Partially Neutralizing Potency against Emerging Genotype I Virus among Children Received Formalin-Inactivated Japanese Encephalitis Virus Vaccine
por: Fan, Yi-Chin, et al.
Publicado: (2012)

Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis
por: Cheng, Yi-Ling, et al.
Publicado: (2022)

Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model
por: Tien, Sen-Mao, et al.
Publicado: (2022)

Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?
por: Galula, Jedhan Ucat, et al.
Publicado: (2019)

Strategically examining the full-genome of dengue virus type 3 in clinical isolates reveals its mutation spectra
por: Chao, Day-Yu, et al.
Publicado: (2005)

Application of Next-Generation Sequencing to Reveal How Evolutionary Dynamics of Viral Population Shape Dengue Epidemiology
por: Ko, Hui-Ying, et al.
Publicado: (2020)

Sculpting humoral immunity through dengue vaccination to enhance protective immunity
por: Crill, Wayne D., et al.
Publicado: (2012)

Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III
por: Fan, Yi-Chin, et al.
Publicado: (2015)

The Antiviral Activity of Varenicline against Dengue Virus Replication during the Post-Entry Stage
por: Lin, Ching-Lin, et al.
Publicado: (2023)

Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo
por: Chuang, Fu-Kai, et al.
Publicado: (2020)

Dengue virus serotype did not contribute to clinical severity or mortality in Taiwan’s largest dengue outbreak in 2015
por: Tsai, Jih-Jin, et al.
Publicado: (2023)

Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection
por: Lai, Yen-Chung, et al.
Publicado: (2017)

A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2017)

Human antibody response to dengue virus: implications for dengue vaccine design
por: Moi, Meng Ling, et al.
Publicado: (2016)

Fever Screening at Airports and Imported Dengue
por: Shu, Pei-Yun, et al.
Publicado: (2005)

The Development of Peptide-based Antimicrobial Agents against Dengue Virus
por: Huang, Yen-Wei, et al.
Publicado: (2018)

Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes
por: Mattia, Kimberly, et al.
Publicado: (2011)

Dengue Virus Targets the Adaptor Protein MITA to Subvert Host Innate Immunity
por: Yu, Chia-Yi, et al.
Publicado: (2012)

Genotype I of Japanese Encephalitis Virus Virus-like Particles Elicit Sterilizing Immunity against Genotype I and III Viral Challenge in Swine
por: Fan, Yi-Chin, et al.
Publicado: (2018)

Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus)
por: Azami, Nor Azila Muhammad, et al.
Publicado: (2018)

Anti-Dengue E-dimer epitope human antibodies have therapeutic activity against Zika virus infection
por: Fernandez, Estefania, et al.
Publicado: (2017)

Publisher Correction: A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2018)

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
por: Zhao, Hui, et al.
Publicado: (2014)

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus
por: Swanstrom, J. A., et al.
Publicado: (2016)

Inter- and intra-host sequence diversity reveal the emergence of viral variants during an overwintering epidemic caused by dengue virus serotype 2 in southern Taiwan
por: Ko, Hui-Ying, et al.
Publicado: (2018)

NS2B/NS3 mutations enhance the infectivity of genotype I Japanese encephalitis virus in amplifying hosts
por: Fan, Yi-Chin, et al.
Publicado: (2019)

Seroprevalence of Zika and Dengue Virus Antibodies among Migrant Workers, Taiwan, 2017
por: Perng, Guey Chuen, et al.
Publicado: (2019)

A novel reporter system for neutralizing and enhancing antibody assay against dengue virus
por: Song, Ke-Yu, et al.
Publicado: (2014)

Therapeutic Efficacy of Antibodies Lacking FcγR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies
por: Williams, Katherine L., et al.
Publicado: (2013)

Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults
por: Saito, Yuka, et al.
Publicado: (2016)

Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
por: Sootichote, Rochanawan, et al.
Publicado: (2023)

Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer
por: Lu, Ruei‐Min, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ukd8icgob8ci0gva5jrvikh102